Home

Sean Salmon

CIK 1792380 · EVP & President Cardiovascular · last filed 2026-08-12

Sean Salmon is an EVP & President Cardiovascular who has filed 24 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ADGM, was dated Aug 12, 2026. Across all open-market trades the lifetime net is −$7.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.9M across reported positions. 23 SEC filings were submitted jointly with Medtronic plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.89M

Companies

2

Total Filings

24

Lifetime Open-Market Net

-$7.76M

Filer Profile

Reported Address
MEDTRONIC PLC, 710 MEDTRONIC PARKWAY
LC300
MINNEAPOLIS, MN 55432
Related Filers
Medtronic plc — 23 joint filings, latest 2025-06-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ADGM Director — $0.56 — $0 2 2026-08-12
MDT EVP & President Cardiovascular 64,722 $90.96 $5.89M -$7.76M 20 2024-12-17

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-12 ADGM Grant (A) — $0 EDGAR
2025-12-11 ADGM Grant (A) — $0 EDGAR
2025-06-06 MDT Notice (144) −18,378 -$1.60M EDGAR
2024-12-17 MDT Tax (F) −645 -$53.2K EDGAR
2024-08-06 MDT Mixed +2,026 -$280.1K EDGAR
2024-07-31 MDT Grant (A) +14,375 $0 EDGAR
2024-02-23 MDT Mixed — -$492.9K EDGAR
2024-02-21 MDT Notice (144) −30,695 -$2.61M EDGAR
2023-12-12 MDT Tax (F) −435 -$34.5K EDGAR
2023-08-07 MDT Mixed +1,235 -$369.1K EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.